29-04-2025 14:00 via wallstreet-online.de

Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology

LAS VEGAS, NEVADA / ACCESS Newswire / April 29, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early …
Jetzt den vollständigen Artikel lesen
Weiterlesen »